Scapho PFP Injection 1's belongs to the class of monoclonal antibodies. It is primarily indicated for the treatment of moderate to severe plaque psoriasis in patients six years and older who are candidates for systemic therapy or phototherapy, active psoriatic arthritis (PsA) in patients two years and older; adults with active ankylosing spondylitis (AS), adults with active non-radiographic axial spondyloarthritis (nr-axSpA).

Scapho PFP Injection 1's consists of Secukinumab. It works by inhibiting the release of inflammatory cytokines and chemokines that contribute to autoimmune and inflammatory diseases.

Scapho PFP Injection 1's is a parenteral medicine. A trained healthcare professional will administer it. Hence, do not self-administer. Scapho PFP Injection 1's may cause side effects such as mild nose and throat infection, diarrhoea, upper respiratory tract infection, and injection site reactions. These side effects do not require medical attention or resolve over time.

Before taking Scapho PFP Injection 1's, inform your doctor about all your allergic or hypersensitivity reactions to medicines or food. Also, tell your doctor about your medical history and other medications you are currently taking to rule out any potential negative effects. Secukinumab is not recommended if you are pregnant. If you become pregnant while taking secukinumab, notify your healthcare professional immediately. Breastfeeding mothers should inform the physician whether to stop or nurse the child while on treatment.

Scapho PFP Injection 1's is used in the treatment of Moderate to severe plaque psoriasis, Active psoriatic arthritis, Active ankylosing spondylitis and Active non-radiographic axial spondyloarthritis. The detailed uses of Scapho PFP Injection 1's are as follows:

• Plaque psoriasis: Scapho PFP Injection 1's is used for treating moderate to severe plaque psoriasis in adults and children aged 6 years and older who are candidates for systemic therapy or phototherapy. It helps reduce the scaly, red, and itchy patches by targeting the inflammatory protein IL-17A.
• Psoriatic arthritis (PsA): Scapho PFP Injection 1's is used alone or with other medications like methotrexate to treat active psoriatic arthritis in adults and children aged 2 years and older. It helps reduce joint pain, swelling, and stiffness while improving physical function.
• Ankylosing spondylitis (AS): Scapho PFP Injection 1's is indicated for adults with active ankylosing spondylitis, a type of arthritis that primarily affects the spine and sacroiliac joints, causing pain and stiffness.
• Non-radiographic axial spondyloarthritis (nr-axSpA): Scapho PFP Injection 1's is used in adults with this form of inflammatory arthritis that affects the spine but does not show up on X-rays, provided there are objective signs of inflammation.
• Enthesitis-related arthritis (ERA): Scapho PFP Injection 1's is approved for children aged 4 years and older with active ERA, a subtype of juvenile idiopathic arthritis that causes inflammation where tendons and ligaments attach to bone.
• Hidradenitis suppurativa (HS): Scapho PFP Injection 1's is also used to treat moderate to severe HS, a chronic skin condition that causes painful lumps, abscesses, and scarring, typically in areas like the armpits and groin.

• Be sure to follow your doctor’s recommendations for the correct dosage and timing of this medication.
• Check the label for directions and use Scapho PFP Injection 1's as advised by the doctor. Inject the advised dose anywhere near the front of your thighs (upper leg) or abdomen (stomach) except your navel and the area 2 inches (5 centimetres) around it.
• Rotate the injection site each time. Do not inject into skin that is red, bruised, or hard.

Scapho PFP Injection 1's consists of Secukinumab, which belongs to the class of monoclonal antibodies. Scapho PFP Injection 1's binds to the interleukin-17A cytokine and inhibits the interaction with the IL-17 receptor. In simple terms, it inhibits the release of inflammatory cytokines and chemokines that contribute to autoimmune and inflammatory diseases. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.

Before taking Scapho PFP Injection 1's, inform your doctor about all your allergic or hypersensitivity reactions to medicines or food. Also, tell your doctor about your medical history and other medications you are currently taking to rule out any potential negative effects. Scapho PFP Injection 1's is not recommended in populations with serious infections, hypersensitivity reactions, Tuberculosis (TB), inflammatory bowel disease, and Eczematous Eruptions (skin reactions). So, inform your healthcare professional about all your medical conditions and any allergic reactions to food or medications. Do not take any vaccinations, especially live while on therapy with this medicine. Scapho PFP Injection 1's is not recommended if you are pregnant. If you become pregnant while taking secukinumab, notify your healthcare professional immediately. A breastfeeding mother should inform the physician whether to stop or nurse the child while on treatment.